Unraveling Parkinson's Disease: A Comprehensive Overview for Healthcare Professionals
OthersPage Navigation
Introduction
Parkinson's disease (PD) is a chronic, progressive neurodegenerative disorder that primarily affects movement. Characterized by the degeneration of dopaminergic neurons in the substantia nigra, PD presents a complex clinical challenge necessitating a comprehensive understanding by healthcare professionals.
Etiology and Pathophysiology
While the exact cause of PD remains unknown, it is thought to result from a combination of genetic and environmental factors. Pathophysiologically, the loss of dopaminergic neurons leads to an imbalance in the basal ganglia's neurotransmitter levels, resulting in the motor symptoms of PD.
Clinical Manifestations
PD typically manifests with bradykinesia, rigidity, and resting tremor. Non-motor symptoms such as autonomic dysfunction, cognitive impairment, and mood disorders may also be present. The disease is progressive, with symptoms worsening over time.
Diagnosis
Diagnosis of PD is primarily clinical, based on the presence of cardinal motor symptoms and response to dopaminergic therapy. Neuroimaging can support the diagnosis, but it is not routinely used due to its limited sensitivity and specificity.
Treatment
Management of PD involves pharmacological therapy to enhance dopaminergic function, alongside non-pharmacological interventions such as physical therapy. Deep brain stimulation may be considered in advanced cases.
Conclusion
In conclusion, Parkinson's disease is a complex neurodegenerative disorder that requires a comprehensive and multidisciplinary approach to management. As healthcare professionals, it is essential to stay updated on the latest advancements in PD research to provide optimal care to our patients.
Recommended News For You
Recommended Articles For You
Featured News
Featured Articles
Featured Events
Featured KOL Videos
1.
Stem Cell Selection Unneeded for SSc Transplant Therapy?
2.
Radiation from CT scans could account for 5% of all cancer cases a year, study suggests
3.
Do I have prostate cancer? Why a simple PSA blood test alone won't give you the answer
4.
In Hemophilia A and B, a Novel Monoclonal Antibody Reduces Bleeding.
5.
Tumor infiltration of major blood vessels, not metastasis, may be primary cause of cancer death
1.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
2.
Emerging Dysregulated Signaling Pathways in Early-Onset Colorectal Cancer
3.
Exploring the Use of Bevacizumab in Treating Different Types of Cancers
4.
A Closer Look at Poorly Differentiated Carcinoma: Uncovering its Complexities
5.
Unlocking the Secrets of Squamous Cell Carcinoma: New Hope for Patients
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
2.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
3.
A New Era in Managing Cancer-Associated Thrombosis
4.
Navigating the Complexities of Ph Negative ALL - Part IX
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Welcome to Hidoc Dr.
Join to enhance your clinical skills and gain specialized in-depth medical knowledge